{"filing":{"accession_number":"0001193125-26-390562","cik":"0000818686","ticker":"TEVJF","company_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","form":"8-K","filing_date":"2026-09-14","report_date":"2026-09-14","primary_document":"d503082d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526390562/d503082d8k.htm"},"events":[{"id":33263,"run_id":30584,"accession_number":"0001193125-26-390562","anchor_item_number":"8.01","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.75,"summary":"Teva terminated its ADS program and began trading ordinary shares directly on the NYSE under the same ticker \"TEVA\" on September 14, 2026. This is a structural change to the company's listing and share class arrangement that affects how investors hold and trade the security. While not a traditional governance event like a board change or shareholder vote, it is a material corporate action affecting the registrant's capital structure and investor access that would be of interest to shareholders.","company_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVJF","filing_date":"2026-09-14","form":"8-K","submitted_at":null,"items":[{"id":36659,"accession_number":"0001193125-26-390562","item_number":"8.01","item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"Teva terminated its ADS program and began trading ordinary shares directly on the NYSE under the same ticker \"TEVA\" on September 14, 2026. This is a structural change to the company's listing and share class arrangement that affects how investors hold and trade the security. While not a traditional governance event like a board change or shareholder vote, it is a material corporate action affecting the registrant's capital structure and investor access that would be of interest to shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-14T20:09:00.858750+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":36659,"accession_number":"0001193125-26-390562","item_number":"8.01","item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"Teva terminated its ADS program and began trading ordinary shares directly on the NYSE under the same ticker \"TEVA\" on September 14, 2026. This is a structural change to the company's listing and share class arrangement that affects how investors hold and trade the security. While not a traditional governance event like a board change or shareholder vote, it is a material corporate action affecting the registrant's capital structure and investor access that would be of interest to shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-14T20:09:00.858750+00:00","company_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVJF","filing_date":"2026-09-14"}]}